Eduardo Rene Salas - 30 Dec 2024 Form 3 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Eduardo Rene Salas, by Michael A. Goldstein as attorney-in-fact
Issuer symbol
ADMA
Transactions as of
30 Dec 2024
Net transactions value
$0
Form type
3
Filing time
02 Jan 2025, 16:10:35 UTC
Previous filing
25 Jun 2024
Next filing
21 Feb 2025

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney